KRAS and neoplasm: The search for inhibitors of SOS1 has yielded four compounds so far, namely BAY-293, MRTX0902, BI-3406 and BI-1701963, that inhibit KRAS-dependent tumor growth in vitro and in xenograft models [21, 25, 26].